Neuvotion Announces Launch of NeuStim for AI-Guided Brain-Body Interface Platform
Summary
Neuvotion announced the launch of NeuStim, an FDA-cleared product providing non-invasive high-resolution electrical stimulation to muscles for promoting recovery after stroke and spinal cord injury. The company is also developing FocalStim for precise spinal cord stimulation. NeuStion's platform combines AI-guided neuromodulation, brain-computer interface, and brain-body interface technologies for neurorecovery.
Why it matters
This launch adds to the growing toolkit of non-invasive neurotechnology devices for stroke and spinal cord injury rehabilitation. NeuStim's innovative touch-screen interface allows clinicians to pinpoint stimulation targets electronically without manual electrode repositioning. The company's broader brain-body interface platform represents an integrated approach to neurorecovery that combines BCI, neuromodulation, and artificial intelligence.
Want the full NeurotechMag Pro intelligence database?
Access 800+ papers, trials, patents, funding rounds and news items — updated daily.
Start free trial